Next 10 |
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Doximity To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 2, 2024) - Faruqi & Faruqi, LLP, a leading national se...
2024-04-28 22:34:47 ET Summary Doximity's revenue and earnings are growing, but the company's slowing revenue growth and customer churn remain concerns. The company's robust product pipeline and focus on AI-led innovation are positive factors for future growth, along with hiring o...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Doximity To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - April 27, 2024) - Faruqi & Faruqi, LLP, a leading national...
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2024 after market close on May 16, 2024. Doximity will host a conference call and webcast at 2:00 p...
2024-04-25 09:45:06 ET More on Doximity Doximity: Rating Upgrade To Buy As Outlook Turns Positive Doximity, Inc. (DOCS) Q3 2024 Earnings Call Transcript Doximity falls amid short report from Jehoshaphat Research Doximity beats top-line and bottom-line estimat...
Do you, or did you, own shares of Doximity, Inc. (NYSE: DOCS)? Did you purchase your shares between February 9, 2022 and April 1, 2024, inclusive? Did you lose money in your investment in Doximity, Inc.? Do you want to discuss your rights? NEW YORK, NY / ACCESSWIRE / April 24,...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Doximity To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - April 23, 2024) - Faruqi & Faruqi, LLP, a leading national...
Do you, or did you, own shares of Doximity, Inc. (NYSE:DOCS)? Did you purchase your shares between February 9, 2022 and April 1, 2024, inclusive? Did you lose money in your investment in Doximity, Inc.? Do you want to discuss your rights? NEW YORK, NY / ACCESSWIRE / April 19, 2...
2024-04-10 01:00:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. We trimmed several of ...
ATLANTA, April 01, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS) complied with federal securities laws. On April 1, 2024, Jehoshaphat Research published a report alleging, among ...
News, Short Squeeze, Breakout and More Instantly...
Doximity Inc. Class A Company Name:
DOCS Stock Symbol:
NYSE Market:
LOS ANGELES, April 30, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class...
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2024 after market close on May 16, 2024. Doximity will host a conference call and webcast at 2:00 p...
LOS ANGELES, April 24, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class...